Europese Unie - Nederlands - EMA (European Medicines Agency)

taw pharma (ireland) limited - clopidogrel hydrochloride - peripheral vascular diseases; stroke; myocardial infarction; acute coronary syndrome - antitrombotische middelen - , , , , secondary prevention of atherothrombotic events, , clopidogrel is indicated in: , - adult patients suffering from myocardial infarction (from a few days until less than 35 days), ischaemic stroke (from 7 days until less than 6 months) or established peripheral arterial disease. , - adult patients suffering from acute coronary syndrome:,    - non-st segment elevation acute coronary syndrome (unstable angina or non-q-wave myocardial infarction), including patients undergoing a stent placement following percutaneous coronary intervention, in combination with acetylsalicylic acid (asa). ,     - st segment elevation acute myocardial infarction, in combination with asa in medically treated patients eligible for thrombolytic therapy. , , in patients with moderate to high-risk transient ischaemic attack (tia) or minor ischaemic stroke (is), clopidogrel in combination with asa is indicated in:, - adult patients with moderate to high-risk tia (abcd2  score ≥4) or minor is (nihss  ≤3) within 24 hours of either the tia or is event.  , , prevention of atherothrombotic and thromboembolic events in atrial fibrillation, in adult patients with atrial fibrillation who have at least one risk factor for vascular events, are not suitable for treatment with vitamin k antagonists (vka) and who have a low bleeding risk, clopidogrel is indicated in combination with asa for the prevention of atherothrombotic and thromboembolic events, including stroke. , , for further information please refer to section 5. , , ,.

Europese Unie - Nederlands - EMA (European Medicines Agency)

viatris limited - clopidogrelbesilaat - peripheral vascular diseases; stroke; myocardial infarction - antitrombotische middelen - secondary prevention of atherothrombotic events clopidogrel is indicated in:adult patients suffering from myocardial infarction (from a few days until less than 35 days), ischemic stroke (from 7 days until less than 6 months) or established peripheral arterial disease. adult patients suffering from acute coronary syndrome. non-st segment elevation acute coronary syndrome (unstable angina or non-q-wave myocardial infarction), including patients undergoing a stent placement following percutaneous coronary intervention, in combination with acetylsalicylic acid (asa). het st-segment elevatie acuut myocardinfarct, in combinatie met asa in medisch behandelde patiënten in aanmerking komen voor trombolytische therapie. in patients with moderate to high-risk transient ischaemic attack (tia) or minor ischaemic stroke (is) clopidogrel in combination with asa is indicated in:adult patients with moderate to high-risk tia (abcd2 score ≥4) or minor is (nihss ≤3) within 24 hours of either the tia or is event. prevention of atherothrombotic and thromboembolic events in atrial fibrillation:in adult patients with atrial fibrillation who have at least one risk factor for vascular events, are not suitable for treatment with vitamin k antagonists (vka) and who have a low bleeding risk, clopidogrel is indicated in combination with asa for the prevention of atherothrombotic and thromboembolic events, including stroke. voor meer informatie refereer je naar sectie 5.

België - Nederlands - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

astellas pharma bv-srl - amoxicillinetrihydraat - eq. amoxicilline 500 mg - oplosbare tablet - 500 mg - amoxicillinetrihydraat - amoxicillin

België - Nederlands - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

astellas pharma bv-srl - amoxicillinetrihydraat - eq. amoxicilline 1 g - oplosbare tablet - 1 g - amoxicillinetrihydraat - amoxicillin

België - Nederlands - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

astellas pharma bv-srl - tacrolimus 5 mg/ml - concentraat voor oplossing voor infusie - 5 mg/ml - tacrolimus 5 mg/ml - tacrolimus

België - Nederlands - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

astellas pharma bv-srl - tacrolimus 5 mg - capsule, hard - 5 mg - tacrolimus 5 mg - tacrolimus

België - Nederlands - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

astellas pharma bv-srl - tacrolimus 1 mg - capsule, hard - 1 mg - tacrolimus 1 mg - tacrolimus

België - Nederlands - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

astellas pharma bv-srl - tacrolimus 0,5 mg - capsule, hard - 0,5 mg - tacrolimus 0.5 mg - tacrolimus

België - Nederlands - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

teva pharma belgium sa-nv - quetiapinefumaraat 57,5 mg - eq. quetiapine 50 mg - tablet met verlengde afgifte - 50 mg - quetiapinefumaraat 57.5 mg - quetiapine

België - Nederlands - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

teva pharma belgium sa-nv - quetiapinefumaraat 230 mg - eq. quetiapine 200 mg - tablet met verlengde afgifte - 200 mg - quetiapinefumaraat 230 mg - quetiapine